Database of mouse strains carrying targeted mutations in genes affecting biological responses to DNA damage: Version 5

DNA Repair

Volumn 2, Issue 5, 2003, Pages 501-530

  Friedberg, Errol C ^a   Meira, Lisiane B ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Biological responses to DNA damage; DNA repair; Knock out mutants; Mice; Mouse mutants; Mutagenesis

Indexed keywords

GENE PRODUCT;

ARTICLE; DATA BASE; DNA REPAIR; DNA STRAND BREAKAGE; DNA SYNTHESIS; EXCISION REPAIR; GENE MUTATION; GENE TECHNOLOGY; MISMATCH REPAIR; MOUSE STRAIN; PHENOTYPE; PRIORITY JOURNAL;

EID: 0037435418     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-7864(03)00005-3     Document Type: Article

References (137)

1. Friedberg E.C., Meira L.B. Database of mouse strains carrying targeted mutations in genes affecting biological responses to DNA damage. Version 4. Mutat. Res. 459:2000;243-274.
2. Tsuzuki T., Sakumi K., Shiraishi A., Kawate H., Igarashi H., Iwakuma T., Tominaga Y., Zhang S., Shimizu S., Ishikawa T., Nakamura K., Nakao K., Katsuki M., Sekiguchi M. Targeted disruption of the DNA repair methyltransferase gene renders mice hypersensitive to alkylating agent. Carcinogenesis. 17:1996;1215-1220.
3. Glassner B.J., Weeda G., Allan J.M., Broekhof J.L., Carls N.H., Donker I., Engelward B.P., Hampson R.J., Hersmus R., Hickman M.J., Roth R.B., Warren H.B., Wu M.M., Hoeijmakers J.H., Samson L.D. DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents. Mutagenesis. 14:1999;339-347.
4. Kawate H., Sakumi K., Tsuzuki T., Nakatsuru Y., Ishikawa T., Takahashi S., Takano H., Noda T., Sekiguchi M. Separation of killing and tumorigenic effects of an alkylating agent in mice defective in two of the DNA repair genes. Proc. Natl. Acad. Sci. U.S.A. 95:1998;5116-5120.
5. Gu H., Marth J.D., Orban P.C., Mossmann H., Rajewsky K. Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting. Science. 265:1994;103-106.
6. Xanthoudakis S., Smeyne R.J., Wallace J.D., Curran T. The redox/DNA repair protein, Ref1, is essential for early embryonic development in mice. Proc. Natl. Acad. Sci. U.S.A. 93:1996;8919-8923.
7. Meira L.B., Devaraj S., Kisby G.E., Burns D.K., Daniel R.L., Hammer R.E., Grundy S., Jialal I., Friedberg E.C. Heterozygosity for the mouse Apex gene results in phenotypes associated with oxidative stress. Cancer Res. 61:2001;5552-5557.
8. Ludwig D.L., MacInnes M.A., Takiguchi Y., Purtymun P.E., Henrie M., Flannery M., Meneses J., Pedersen R.A., Chen D.J. A murine AP-endonuclease gene-targeted deficiency with post-implantation embryonic progression and ionizing radiation sensitivity. Mutat. Res. 409:1998;17-29.
9. Bentley D., Selfridge J., Millar J.K., Samuel K., Hole N., Ansell J.D., Melton D.W. DNA ligase I is required for fetal liver erythropoiesis but is not essential for mammalian cell viability. Nat. Genet. 13:1996;489-491.
10. Takao M., Kanno S.-I., Shiromoto T., Hasegawa R., Ide H., Ikeda S., Sarker A.H., Seki S., Xing J.Z., Le X.C., Weinfeld M., Kobayashi K., Miyazaki J.-I., Muijtjens M., Hoeijmakers J.H.J., van der Horst G., Yasui A. Novel nuclear and mitochondrial glycosylases revealed by disruption of the mouse Nth1 gene encoding an endonuclease III homolog for repair of thymine glycols. EMBO J. 21:2002;3486-3493.
11. Ocampo M.T.A., Chaung W., Marenstein D.R., Chan M.K., Altamirano A., Basu A.K., Boorstein R.J., Cunningham R.P., Teebor G.W. Targeted deletion of mNth1 reveals a novel DNA repair enzyme activity. Mol. Cell. Biol. 22:2002;6111-6121.
12. Klunglund A., Rosewell I., Hollenbach S., Larsen E., Daly G., Epe B., Seeberg E., Lindahl T., Barnes D.E. Accumulation of pre-mutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc. Natl. Acad. Sci. U.S.A. 96:1999;13300-13305.
13. Nilsen H., Rosewell I., Robins P., Skjelbred C.F., Andersen S., Slupphaug G., Daly G., Krokan H.E., Lindahl T., Barnes D.E. Uracil-DNA glycosylase (UNG)-deficient mice reveal a primary role of the enzyme during DNA replication. Mol. Cell. 5:2000;1059-1065.
14. Engelward B.P., Weeda G., Wyatt M.D., Broekhof J.L., de Wit J., Donker I., Allan J.M., Gold B., Hoeijmakers J.H.J., Samson L.D. Base excision repair deficient mice lacking the Aag alkyladenine DNA glycosylase. Proc. Natl Acad. Sci. U.S.A. 94:1997;13087-13092.
15. 4-ethenocytosine or 8-oxoguanine. Proc. Natl Acad. Sci. U.S.A. 94:1997;12869-12874. (this is the same mouse as mentioned in [16]).
16. Elder R.H., Jansen J.G., Weeks R.J., Willington M.A., Deans B., Watson A.J., Mynett K.J., Bailey J.A., Cooper D.P., Rafferty J.A., Heeran M.C., Wijnhoven S.W., van Zeeland A.A., Margison G.P. Alkylpurine-DNA-N-glycosylase knockout mice show increased susceptibility to induction of mutations by methyl methanesulfonate. Mol. Cell. Biol. 18:1998;5828-5837. (this is the primary reference, even though in 1998, the mouse mentioned in [15] is the same mouse).
17. H. Yang, J.H. Miller, unpublished observations.
18. McWhir J., Selfridge J., Harrison D.J., Squires S., Melton D.W. Mice with DNA repair gene (Ercc1) deficiency have elevated levels of p53. Nat. Genet. 5:1993;217-224.
19. Weeda G., Donker I., de Wit J., Morreau H., Janssens R., Vissers C.J., Nigg A., van Steeg H., Bootsma D., Hoeijmakers J.H.J. Disruption of the mouse Ercc1 gene results in a novel repair syndrome with growth failure. Curr. Biol. 7:1997;427-439.
20. de Vries A., van Oostrom C.T.M., Hofhuis F.M.A., Dortant P.M., Berg R.J.W., de Gruijl F.R., Wester P.W., van Kreijl C.F., Capel P.J.A., van Steeg H., Verbeek S.J. Increased susceptibility to ultraviolet-B and carcinogenesis in mice lacking the DNA repair gene Xpa. Nature. 377:1995;169-173.
21. Nakane H., Takeuchi S., Yuba S., Saijo M., Nakatsu Y., Murai H., Nakatsuru Y., Ishikawa T., Hirota S., Kitamura Y., Kato Y., Tsunoda Y., Miyauchi H., Horio T., Tokunaga T., Matsunaga T., Nikaido O., Nishimune Y., Okada Y., Tanaka K. High incidence of ultraviolet-B or chemical carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene. Nature. 377:1995;165-168.
22. de Vries A., Berg R.J.W., Wijnhoven S., Westerman A., Wester P.W., van Kreijl C.F., Capel P.J.A., de Gruijl F.R., van Kranen H.J., van Steeg H. Xpa-deficiency in hairless mice causes a shift in skin tumor types and mutational target genes after exposure to low doses of UVB. Oncogene. 16:1998;2205-2212.
23. Sands A.T., Abuin A., Sanchez A., Conti C.J., Bradley A. High susceptibility to ultraviolet-induced carcinogenesis in mice lacking Xpc. Nature. 377:1995;162-165.
24. Cheo D.L., Ruven H.J.T., Meira L.B., Hammer R.E., Burns D.K., Tappe N.J., van Zeeland A.A., Mullenders L.H.F., Friedberg E.C. Characterization of defective nucleotide excision repair in Xpc mutant mice generated by targeted gene replacement. Mutat. Res. 374:1997;1-9.
25. G.T.J. van der Horst, H. van Steeg, K. Tanaka, A. Bradley, J.H.J. Hoeijmakers, et al., manuscript in preparation.
26. Cheo D.L., Meira L.B., Hammer R.E., Burns D.K., Doughty A.T.B., Friedberg E.C. Synergistic interactions between Xpc and p53 mutations in double mutant mice: neural tube abnormalities and accelerated UV radiation-induced skin cancer. Curr. Biol. 6:1996;1691-1694.
27. Meira L.B., Cheo D.L., Reis A., Hammer R.E., Burns D.K., Friedberg E.C. Genetic interaction between Hap1 (Ref1) and p53. Nat. Genet. 17:1997;145.
28. Cheo D.L., Meira L.B., Burns D.K., Reis A.M., Issac T., Friedberg E.C. UVB radiation-induced skin cancer in mice defective in the Xpc, Trp53, and Apex (Hap1) genes: genotype-specific effects on cancer predisposition and pathology of tumors. Cancer Res. 60:2000;1580-1584.
29. Meira L.B., Cheo D.L., Reis A.M., Claij N., Burns D.K., te Riele H., Friedberg E.C. Mice defective in the mismatch repair gene Msh2 show increased predisposition to UVB radiation-induced skin cancer. DNA Repair. 1:2002;929-934. (Erratum on DNA Repair 1 (2002) 1063).
30. G. Weeda, I. Donker, J.L.M. Broekhof, J. de Wit, J.H.J. Hoeijmakers, Lethal and viable targeted mutations in the basal transcription/DNA repair helicase Xpb: a mouse model for the human repair disorder xeroderma pigmentosum, manuscript in preparation.
31. de Boer J., Donker I., de Wit J., Hoeijmakers J.H.J., Weeda G. Disruption of the mouse xeroderma pigmentosum group D DNA repair/basal transcription gene results in pre-implantation lethality. Cancer Res. 58:1998;89-94.
32. de Boer J., de Wit J., van Steeg H., Berg R.J.W., Morreau H., Visser P., Lehmann A.R., Duran M., Hoeijmakers J.H.J., Weeda G. A mouse model for the basal transcription/DNA repair syndrome trichothiodystrophy. Mol. Cell. 1:1998;981-990.
33. Harada Y.-N., Shiomi N., Koike M., Ikawa M., Okabe M., Hirota S., Kitamura Y., Kitagawa M., Matsunaga T., Nakaido O., Shiomi T. Post-natal growth failure, a short life span, and early onset of cellular senescence and subsequent immortalization in mice lacking the xeroderma pigmentosum group G gene. Mol. Cell. Biol. 19:1999;2366-2372.
34. T. Shiomi, personal communication.
35. J.M.Y. Ng, K. Sugasawa, H. Vrieling, J.H.J. Hoeijmakers, G.T.J. van der Horst, et al., manuscript in preparation.
36. Ng J.M.Y., Vrieling H., Sugasawa K., Ooms M.P., Grootegood J.A., Vreeburg J.T.M., Visser P., Beems R.B., Gorgels T.G.M.F., Hanaoka F., Hoeijmakers J.H.J., van der Horst G.T.J. Developmental defects and male sterility in mice lacking the ubiquitin-Like DNA repair gene mHR23B. Mol. Cell. Biol. 22:2002;1233-1245.
37. van der Horst G.T.J., Meira L.B., Gorgels T.G.M.F., de Wit J., Velasco-Miguel S., Richardson J.A., Kamp Y., Vreeswijk M.P.G., Smit B., Bootsma D.et al. UVB radiation-induced cancer predisposition in Cockayne syndrome group A (Csa) mutant mice. DNA Repair. 1:2002;143-157.
38. van der Horst G.T.J., van Steeg H., Berg R.J.W., van Gool A.J., de Wit J., Weeda G., Morreau H., Beems R.B., van Kreijl C.F., de Gruijl F.R., Bootsma D., Hoeijmakers J.H.J. Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition. Cell. 89:1997;425-435.
39. Murai M., Enokido Y., Inamura N., Yoshino M., Nakatsu Y., van der Horst G.T.J., Hoeijmakers J.H.J., Tanaka K., Hatanaka H. Early post-natal ataxia and abnormal cerebellar development in mice lacking xeroderma pigmentosum group A and Cockayne syndrome group B DNA repair genes. Proc. Natl. Acad. Sci. U.S.A. 98:2001;13379-13384.
40. Wong E., Yang K., Kuraguchi M., Werling U., Avdievich E., Fan K., Fazzari M., Jin B., Brown A.M.C., Lipkin M., Edelmann W. Mbd4 inactivation increases C → T transition mutations and promotes gastrointestinal tumor formation. Proc. Natl. Acad. Sci. U.S.A. 99:2002;14937-14942.
41. Millar C.B., Guy J., Sansom O.J., Selfridge J., MacDougall E., Hendrich B., Keightley P.D., Bishop S.M., Clarke A.R., Bird A. Enhanced CpG mutability and tumorigenesis in Mbd4-deficient mice. Science. 297:2002;403-405.
42. Prolla T.A., Baker S.M., Harris A.C., Tsao J.-L., Yao X., Bronner C.E., Zheng B., Gordon M., Reneker J., Arnheim N., Shibata D., Bradley A., Liskay R.M. Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1. Nat. Genet. 18:1998;276-279.
43. Baker S.M., Bronner C.E., Zhang L., Plug A.W., Robatzek M., Warren G., Elliott E.A., Yu J., Ashley T., Arnheim N., Flavell R.A., Liskay R.M. Male mice defective in the DNA mismatch repair gene Pms2 exhibit abnormal chromosome synapsis in meiosis. Cell. 82:1995;309-319.
44. -/-; Min mice. Cancer Res. 58:1998;1087-1089.
45. de Wind N., Dekker M., Berns A., Radman M., te Riele H. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell. 82:1995;321-330.
46. Reitmair A.H., Schmits R., Ewel A., Bapat B., Redston M., Mitri A., Waterhouse P., Mittrucker H.W., Wakeham A., Liu B., Thomason A., Griesser H., Gallinger S., Ballhausen W.G., Fishel R., Mak T.W. Msh2-deficient mice are viable and susceptible to lymphoid tumors. Nat. Genet. 11:1995;64-70.
47. Reitmair A.H., Cai J.C., Bjerknes M., Redston M., Cheng H., Pind M.T.L., Hay K., Mitri A., Bapat B.V., Mak T.W., Gallinger S. Msh2 deficiency contributes to accelerated Apc-mediated intestinal tumorigenesis. Cancer Res. 56:1996;2922-2926.
48. de Wind N., Dekker M., van Rossum A., van der Valk M., te Riele H. Mouse models for hereditary nonpolyposis colorectal cancer. Cancer Res. 58:1998;248-255.
49. Cranston A., Bocker T., Reitmair A., Wilson J., Palazzo T., Mak T., Fishel R. Female embryonic lethality in mice nullizygous for both Msh2 and p53. Nat. Genet. 17:1997;114-118.
50. Toft N.J., Arends M.J., Wyllie A.H., Clarke A.R. No female embryonic lethality in mice nullizygous for Msh2 and p53. Nat. Genet. 18:1998;17.
51. D.L. Cheo, L.B. Meira, H. te Riele, E.C. Friedberg, unpublished observations.
52. Edelmann W., Umar A., Yang K., Heyer J., Kucherlapati M., Lia M., Kneitz B., Avdievich E., Fan K., Wong E., Crouse G., Kunkel T., Lipkin M., Kolodner R.D., Kucherlapati R. The DNA mismatch repair genes Msh3 and Msh6 cooperate in intestinal tumor suppression. Cancer Res. 60:2000;803-807.
53. 1638N mice define the roles of Msh3 and Msh6 in DNA repair and intestinal tumorigenesis. Cancer Res. 61:2001;7934-7942.
54. Kneitz B., Cohen P.E., Avdievich E., Zhu L., Kane M.F., Hou H. Jr., Kolodner R.D., Kucherlapati R., Pollard J.W., Edelmann W. MutS homolog 4 localization to meiotic chromosomes is required for chromosome pairing during meiosis in male and female mice. Genes Dev. 14:2000;1085-1097.
55. de Vries S.S., Baart E.B., Dekker M., Siezen A., de Rooij D.G., de Boer P., te Riel H. Mouse MutS-like protein Msh5 is required for proper chromosome synapsis in male and female meiosis. Genes Dev. 13:1999;523-531.
56. Edelmann W., Yang K., Umar A., Heyer J., Lau K., Fan K., Liedtke W., Cohen P.E., Kane M.F., Lipford J.R., Yu N., Crouse G.F., Pollard J.W., Kunkel T., Lipkin M., Kolodner R., Kucherlapati R. Mutation in the mismatch repair gene Msh6 causes cancer susceptibility. Cell. 91:1997;467-477.
57. Baker S.M., Plug A.W., Prolla T.A., Bronner C.E., Harris A.C., Yao X., Christie D.-M., Monell C., Arnheim N., Bradley A., Ashley T., Liskay R.M. Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nat. Genet. 13:1996;336-342.
58. Edelmann W., Cohen P.E., Kane M., Lau K., Morrow B., Bennett S., Umar A., Kunkel T., Cattoretti G., Chaganti R., Pollard J.W., Kolodner R.D., Kucherlapati R. Meiotic pachytene arrest in Mlh1-deficient mice. Cell. 85:1996;1125-1134.
59. 1638N mutant mice. Cancer Res. 59:1999;1301-1307.
60. Lipkin S.M., Moens P.B., Wang V., Lenzi M., Shanmugarajah D., Gilgeous A., Thomas J., Cheng J., Touchman J.W., Green E.D., Schwartzberg P., Collins F.S., Cohen P.E. Meiotic arrest and aneuploidy in Mlh3-deficient mice. Nat. Genet. 31:2002;385-390.
61. Yao X., Buermeyer A.B., Narayanan L., Tran D., Baker S.M., Prolla T.A., Glazer P.M., Liskay R.M., Arnheim N. Different mutator phenotypes in Mlh1- versus Pms2-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 96:1999;6850-6855.
62. Wang H., Douglas W., Lia M., Edelmann W., Kucherlapati R., Podsypanina K., Parsons R., Ellenson L.H. DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice. Am. J. Pathol. 160:2002;1481-1486.
63. Min/+ mice. Oncogene. 19:2000;2774-2779.
64. Goldsby R.E., Lawrence N.A., Hays L.E., Olmsted E.A., Chen X., Singh M., Preston B.D. Defective DNA polymerase-δ proofreading causes cancer susceptibility in mice. Nat. Med. 7:2001;638-639.
65. Tebbs R.S., Flannery M.L., Meneses J.J., Hartmann A., Tucker J.D., Thompson L.H., Cleaver J.E., Pederson R.A. Requirement for the Xrcc1 DNA base excision repair gene during early mouse development. Dev. Biol. 208:1999;513-529.
66. Deans B., Griffin C.S., Maconochie M., Thacker J. Xrcc2 is required for genetic stability. EMBO J. 19:2000;6675-6685.
67. Gao Y., Sun Y., Frank K.M., Dikkes P., Fujiwara Y., Seidl K.J., Sekiguchi J.M., Rathbun G.A., Swat W., Wang S., Bronson R.T., Malynn B.A., Bryans M., Zhu C., Chaudhuri J., Davidson L., Ferrini R., Stamato T., Orkin S.H., Greenberg M.E., Alt F.W. A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell. 95:1998;891-902.
68. Zhu C., Bogue M.A., Lim D.-S., Hasty P., Roth D.B. Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell. 86:1996;379-389.
69. Nussenzweig A., Chen C., de Costa Soares V., Sanchez M., Sokol K., Nussenzweig M.C., Li G.C. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature. 382:1996;551-555.
70. Ouyang H., Nussenzweig A., Kurimasa A., de Costa Soares V., Li X., Cordon-Cardo C., Li W.-H., Cheong N., Nussenzweig M., Iliakis G., Chen D.J., Li G.C. Ku70 is required for DNA repair but not for T cell antigen receptor gene recombination in vivo. J. Exp. Med. 186:1997;921-929.
71. Gu Y., Seidl K.J., Rathbun G.A., Zhu C., Manis J.P., van der Stoep N., Davidson L., Cheng H.-L., Sekiguchi J.M., Frank K., Stanhope-Baker P., Schlissel M.S., Roth D.B., Alt F.W. Growth retardation and leaky Scid phenotype of Ku70-deficient mice. Immunity. 7:1997;653-665.
72. Frank K.M., Sekiguchi J.M., Seidl K.J., Swat W., Rathbun G.A., Cheng H.-L., Davidson L., Kangaloo L., Alt F.W. Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature. 396:1998;173-177.
73. Barnes D.E., Stamp G., Rosewell I., Denzel A., Lindahl T. Targeted disruption of the gene encoding DNA ligase IV leads to lethality in embryonic mice. Curr. Biol. 8:1998;1395-1398.
74. Frank K.M., Sharpless N.E., Gao Y., Sekiguchi J.M., Ferguson D.O., Zhu C., Manis J.P., Horner J., DePinho R.A., Alt F.W. DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol. Cell. 5:2000;993-1002.
75. Gao Y., Chaudhuri J., Zhu C., Davidson L., Weaver D.T., Alt F.W. A targeted Dna-pkcs-null mutation reveals Dna-pk-independent functions for Ku in V(D)J recombination. Immunity. 9:1998;367-376.
76. Taccioli G.E., Amatucci A.G., Beamish H.J., Gell D., Xiang X.H., Torres Arzayus M.I., Priestley A., Jackson S.P., Marshak Rothstein A., Jeggo P.A., Herrera V.L.M. Targeted disruption of the catalytic subunit of the Dna-pk gene in mice confers severe combined immunodeficiency and radiosensitivity. Immunity. 9:1998;355-356.
77. Kurimasa A., Ouyang H., Dong L.-J., Wang S., Li X., Cordon-Cardo C., Chen D.J., Li G.C. Catalytic subunit of DNA-dependent protein kinase: impact on lymphocyte development and tumorigenesis. Proc. Natl. Acad. Sci. U.S.A. 96:1999;1403-1408.
78. Wang Z.-Q., Auer B., Stingl L., Berghammer H., Haidacher D., Schweiger M., Wagner E.F. Mice lacking ADPRT and poly(ADP)-ribosylation develop normally but are susceptible to skin disease. Genes Dev. 9:1995;509-520.
79. de Murcia J.M., Niedergang C., Trucco C., Ricoul M., Dutrillaux B., Mark M., Oliver F.J., Masson M., Dierich A., LeMeur M., Walztinger C., Chambon P., de Murcia G. Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc. Natl. Acad. Sci. U.S.A. 94:1997;7303-7307.
80. Matsutani M., Suzuki H., Kamada N., Watanabe M., Ueda O., Nozaki T., Jishage K.I., Watanabe T., Sugimoto T., Nakagama H., Ochiya T., Sugimura T. Poly(ADP-ribose) polymerase gene disruption conferred mice resistance to streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. U.S.A. 96:1999;2301-2304.
81. Morrison C., Smith G.C.M., Stingl L., Jackson S.P., Wagner E.F., Wang Z.Q. Genetic interaction between Parp and Dna-pk in V(D)J recombination and tumorigenesis. Nat. Genet. 17:1997;479-482.
82. Celeste A., Petersen S., Romanienko P.J., Fernandez-Capetillo O., Chen H.T., Sedelnikova O.A., Reina-San-Martin B., Coppola V., Meffre E., Difilippantonio M.J., Redon C., Pilch D.R., Olaru A., Eckhaus M., Camerini-Otero R.D., Tessarollo L., Livak F., Manova K., Bonner W.M., Nussenzweig M.C., Nussenzweig A. Genomic instability in mice lacking histone H2ax. Science. 296:2002;922-927.
83. Luo G., Yao M.S., Bender C.F., Mills M., Bladl A.R., Bradley A., Petrini J.H. Disruption of mRad50 causes embryonic stem cell lethality, abnormal embryonic development, and sensitivity to ionizing radiation. Proc. Natl. Acad. Sci. U.S.A. 96:1999;7376-7381.
84. Tsuzuki T., Fujii Y., Sakumi K., Tominaga Y., Nakao K., Sekiguchi M., Matsushiro A., Yoshimura Y., Morita T. Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc. Natl. Acad. Sci. U.S.A. 93:1996;6236-6240.
85. -/- background. Mol. Cell. Biol. 19:1999;8686-8693.
86. Pittman D., Schimenti J. Mid-gestation lethality in mice deficient for the RecA homolog, Rad51d/Rad51L3. Genesis. 26:2000;167-173.
87. Lim D.-S., Hasty P. A mutation in mouse Rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol. Cell. Biol. 16:1996;7133-7143.
88. Rijkers T., van den Ouweland J., Morolli B., Rolink A.G., Baarends W.M., van Sloun P.P.H., Lohman P.H.M., Pastink A. Targeted inactivation of mouse Rad52 reduces homologous recombination but not resistance to ionizing radiation. Mol. Cell. Biol. 18:1998;6423-6429.
89. Essers J., Hendriks R.W., Swagemakers S.M.A., Troelstra C., de Wit J., Bootsma D., Hoeijmakers J.H.J., Kanaar R. Disruption of mouse Rad54 reduces ionizing radiation resistance and homologous recombination. Cell. 89:1997;195-204.
90. Zhu J., Petersen S., Tessarollo L., Nussenzweig A. Targeted disruption of the Nijmegen breakage syndrome gene Nbs1 leads to early embryonic lethality in mice. Curr. Biol. 11:2001;105-109.
91. Kang J., Bronson R.T., Xu Y. Targeted disruption of Nbs1 reveals its roles in mouse development and DNA repair. EMBO J. 21:2002;1447-1455.
92. Xu X., Wagner K.-U., Larson D., Weaver Z., Li C., Ried T., Henninghausen L., Wynshaw-Boris A., Deng C.-X. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat. Genet. 22:1999;37-43.
93. Gowen L.C., Johnson B.L., Latour A.M., Sulik K.K., Koller B.H. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat. Genet. 12:1996;191-194.
94. Shen S.-X., Weaver Z., Xu X., Li C., Weinstein M., Chen L., Guan X.-Y., Ried T., Deng C.-X. A targeted disruption of the murine Brca1 gene causes γ-irradiation hypersensitivity and genetic instability. Oncogene. 17:1998;3115-3124.
95. Liu C.-Y., Flesken-Nikitin A., Li S., Zeng Y., Lee W.-H. Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early post-implantation development. Genes Dev. 10:1996;1835-1843.
96. Sharan S.K., Morimatsu M., Albrecht U., Lim D.-S., Regel E., Dinh C., Sands A., Eichele G., Hasty P., Bradley A. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature. 386:1997;804-810.
97. Ludwig T., Chapman D.L., Papaioannou V.E., Efstratiadis A. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev. 11:1997;1226-1241.
98. Patel K.J., Yu V.P., Lee H., Corcoran A., Thistlthwaite F.C., Evans M.J., Colledge W.H., Friedman L.S., Ponder B.A., Venkitaraman A.R. Involvement of Brca2 in DNA repair. Mol. Cell. 1:1998;347-357.
99. Suzuki A., de la Pompa J.L., Hakem R., Elia A., Yoshida R., Mo R., Niushina H., Chuang T., Wakeham A., Itie A., Koo W., Billia P., Fukumoto M., Wai C.C., Mak T.W. Brca2 is required for embryonic cellular proliferation in the mouse. Genes Dev. 11:1997;1242-1252.
100. Connor F., Bertwistle D., Mee P.J., Ross G.M., Swift S., Grigorieva E., Tybulewicz V.L.J., Ashworth A. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nat. Genet. 17:1997;423-430.
101. Cressman V.L., Backlund D.C., Avrutskaya A.V., Leadon S.A., Godfrey V., Koller V.H. Growth retardation, DNA repair defects, and lack of spermatogenesis in Brca1-deficient mice. Mol. Cell. Biol. 19:1999;7061-7075.
102. Bemark M., Khamlichi A.A., Davies S.L., Neuberger M.S. Disruption of mouse polymerase ζ (Rev3) leads to embryonic lethality and impairs blastocyst development in vitro. Curr. Biol. 10:2000;1213-1216.
103. Wittschieben J., Shivji M.K.K., Lalani E., Jacobs M.A., Marini F., Gearhart P.J., Rosewell I., Stamp G., Wood R.D. Disruption of the developmentally regulated Rev3L gene causes embryonic lethality. Curr. Biol. 10:2000;1217-1220.
104. van Sloun P.P.H., Varlet I., Sonneveld E., Boei J.J.W.A., Romeijn R.J., Eeken J.C.J., De Wind N. Involvement of mouse Rev3 in tolerance of endogenous and exogenous DNA damage. Mol. Cell. Biol. 22:2000;2159-2169.
105. Esposito G., Godin I., Klein U., Yaspo M.-L., Cumano A., Rajewsky K. Disruption of the Rev3L-encoded catalytic subunit of polymerase ζ in mice results in early embryonic lethality. Curr. Biol. 10:2000;1221-1224.
106. Schenten D., Gerlach V.L., Guo C., Velasco-Miguel S., Hiadik C.L., White C.L., Friedberg E.C., Rajewsky K., Esposito G. DNA polymerase κ deficiency does not affect somatic hypermutation in mice. Eur. J. Immunol. 32:2002;3152-3160.
107. Bertocci B., De Smet A., Flatter E., Dahan A., Bories J.-C., Landreau C., Weill J.-C., Reynaud C.-A. Cutting edge: DNA polymerases μ and γ are dispensable for Ig gene hypermutation. J. Immunol. 168:2002;3702-3706.
108. Esposito G., Texido G., Betz U.A., Gu H., Muller W., Rajewsky K. Mice reconstituted with DNA polymerase β-deficient fetal liver cells are able to mount a T cell-dependent immune response and mutate their lg genes normally. Proc. Natl. Acad. Sci. U.S.A. 9:1999;368-373.
109. Kucherlapati M., Yang K., Kuraguchi M., Zhao J., Lia M., Heyer J., Kane M.F., Fan K., Russell R., Brown A.M.C., Kneitz B., Edelmann W., Kolodner R.D., Lipkin M., Kucherlapati R. Haploinsufficiency of flap endonuclease (Fen1) leads to rapid tumor progression. Proc. Natl. Acad. Sci. U.S.A. 99:2002;9924-9929.
110. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A. Jr., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature. 356:1992;215-221.
111. Tsukada T., Tomooka Y., Takai S., Ueda Y., Nishikawa S.I., Yagi T., Tokunaga T., Takeda N., Suda Y., Abe S., Matsuo I., Ikawa Y., Aizawa S. Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene. 8:1993;3313-3322.
112. Jacks T., Remington L., Williams B.O., Schmitt E.M., Halachmi S., Bronson R.T., Weinberg R.A. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4:1994;1-7.
113. Cip1/Waf1 undergo normal development, but are defective in G1 checkpoint control. Cell. 82:1995;675-684.
114. Barlow C., Hirotsune S., Paylor R., Liyanage M., Eckhaus M., Collins F., Shiloh Y., Crawley J.N., Ried T., Tagle D., Wynshaw-Boris A. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell. 86:1996;159-171.
115. Xu Y., Baltimore D. Dual roles of Atm in the cellular response to radiation and in cell growth control. Genes Dev. 10:1996;2401-2410.
116. Xu Y., Ashley T., Brainerd E.E., Bronson R.T., Meyn M.S., Baltimore D. Targeted disruption of Atm leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 10:1996;2411-2422.
117. Barlow C., Liyanage M., Moens P.B., Deng C.-X., Ried T., Wynshaw-Boris A. Partial rescue of the prophase I defects of Atm-deficient mice by p53 and p21 null alleles. Nat. Genet. 17:1997;462-466.
118. Barlow C., Brown K.D., Deng C.-X., Tagle D.A., Wynshaw-Boris A. Atm selectively regulates distinct p53-dependent cell cycle checkpoint and apoptotic pathways. Nat. Genet. 17:1997;453-456.
119. Wang Y.A., Elson A., Leder P. Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in Atm-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 94:1997;14590-14595.
120. -/- mice. Mol. Cell. Biol. 18:1998;4385-4390.
121. Liao M.-J., van Dyke T. Critical role for Atm in suppressing V(D)J recombination-driven thymic lymphoma. Genes Dev. 13:1999;1246-1250.
122. Brown E.J., Baltimore D. Atr disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev. 14:2000;397-402.
123. Liu Q., Guntuku S., Cui X.-S., Matsuoka S., Cortez D., Tamai K., Luo G., Carattini-Rivera S., DeMayo F., Bradley A., Donehower L.A., Elledge S.J. Chk1 is an essential kinase that is regulated by Atr and required for the G2/M DNA damage checkpoint. Genes Dev. 14:2000;1448-1449.
124. Serrano M., Lee H., Chin L., Cordon-Cardo C., Beach D., DePinho R.A. Role of the Ink4a locus in tumor suppression and cell mortality. Cell. 85:1996;27-37.
125. Zindy F., van Deursen J., Grosveld G., Sherr C.J., Roussel M.F. Ink4d-deficient mice are fertile despite testicular atrophy. Mol. Cell. Biol. 20:2000;372-378.
126. Hollander M.C., Sheikh M.S., Bulavin D.V., Lundgren K., Augeri-Henmueller L., Shehee R., Molinaro T.A., Kim K.E., Tolosa E., Ashwell J.D., Rosenberg M.P., Zhan Q., Fernandez-Salguero P.M., Morgan W.F., Deng C.-X., Fornace A.J. Jr. Genomic instability in Gadd45a-deficient mice. Nat. Genet. 23:1999;176-184.
127. H.P. Roest, J.H.J. Hoeijmakers, et al., unpublished observations.
128. Roest H.P., van Klaveren J., de Wit J., van Gurp C.G., Koken M.H.M., Vermey M., van Roijen J.H., Hoogerbrugge J.W., Vreeburg J.T.M., Baarends W.M., Bootsma D., Grootegoed J.A., Hoeijmakers J.H.J. Inactivation of the HR6B ubiquitin-conjugating DNA repair enzyme in mice causes male sterility associated with chromatin modification. Cell. 86:1996;799-810.
129. Lebel M., Leder P. A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity. Proc. Natl. Acad. Sci. U.S.A. 95:1998;13097-13102.
130. Chester N., Kuo F., Kozak C., O'Hara C.D., Leder P. Stage-specific apoptosis, developmental delay, and embryonic lethality in mice homozygous for a targeted disruption in the murine Bloom syndrome gene. Genes Dev. 12:1998;3382-3393.
131. Luo G., Santoro I.M., McDaniel L.D., Nishijima I., Mills M., Youssoufian H., Vogel H., Schultz R.A., Bradley A. Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nat. Genet. 26:2000;424-429.
132. Dronkert M.L.G., de Wit J., Boeve M., Vasconcelos M.L., van Steeg H., Tan T.L.R., Hoeijmakers J.H.J., Kanaar R. Disruption of mouse Snm1 causes increased sensitivity to the DNA interstrand cross-linking agent mitomycin C. Mol. Cell. Biol. 20:2000;4553-4561.
133. Noll M., Battaile K.P., Bateman R., Lax T.P., Rathbun K., Reifsteck C., Bagby G., Finegold M., Olson S., Grompe M. Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex. Exp. Hematol. 30:2002;679-688.
134. Chen M., Tomkins D.J., Auerbach W., McKerlie C., Youssoufian H., Liu L., Gan O., Carreau M., Auerbach A., Groves T., Guidos C.J., Freedman M.H., Cross J., Percy D.H., Dick J.E., Joyner A.L., Buchwald M. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anemia. Nat. Genet. 12:1996;448-451.
135. Whitney M.A., Royle G., Low M., Kelly M.A., Axthelm M.K., Reifsteck C., Olson S., Braun R.E., Heinrich M.C., Rathbun R.K., Bagby G.C., Grompe M. Germ cell defects and hemopoietic hypersensitivity to γ-interferon in mice with a targeted disruption of the Fanconi anemia C gene. Blood. 88:1996;49-58.
136. B. van der Horst, J.H.J. Hoeijmakers, personal communication.
137. S. Velasco-Miguel, E.C. Friedberg, unpublished observation.